Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: The Effects of Short-time High-intensity Interval Training on Tissue Glucose and Fat Metabolism in Healthy Subjects and Patients With Type 2 Diabetes [NA]
Clinical trial update on the effects of short-time high-intensity interval training on tissue glucose and fat metabolism in healthy subjects…
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Effects of Milk Derived From Mountain-pasture Grazing Cows on Risk Markers of the Metabolic Syndrome Compared to Conventional Danish Milk [NA]
A completed clinical trial comparing mountain-pasture milk to conventional Danish milk assessing effects on risk markers of metabolic syndro…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Predictive Genetic Risk Assessment Trial
This Mayo Clinic-sponsored trial on Predictive Genetic Risk Assessment has completed, investigating genetic risk prediction across multiple …
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 study assessing safety, preliminary pharmacodynamics and pharmacokinetics of rExenatide-4 in Chinese patients with Type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Insulin Glargine "All to Target" Trial [Phase 4]
This Phase 4 trial update reports completed results for insulin glargine in type 2 diabetes, with results posted in 2011.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease [Phase 4]
Phase 4 clinical trial update assessing the prognosis and effects of anti-diabetic drugs in patients with type 2 diabetes mellitus and coron…
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients [NA]
This update summarizes a completed clinical trial evaluating whether orally ingested branched-chain amino acids affect delayed onset muscle …
-
CLINICAL_TRIALS research · 2011-04-22Clinical Trial Update: Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft [NA]
This clinical trial update reports on the effects of exercise training on left ventricular function in patients with type 2 diabetes mellitu…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189) [Phase 3]
This Phase 3 clinical trial assessed the efficacy and safety of adding sitagliptin to metformin in patients with type 2 diabetes mellitus wi…
-
CLINICAL_TRIALS safety_alert · 2011-04-18Clinical Trial Update: Fracture Risk With Thiazolidinediones
A clinical trial update examines fracture risk associated with thiazolidinedione therapy in type 2 diabetes, noting potential increased frac…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment [Phase 3]
Phase 3 randomized trial evaluating Lantus (insulin glargine) versus Humalog Mix as add-on therapy in adults with type 2 diabetes failing su…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of adding ursodeoxycholic acid to a DPP-4 inhibitor in adults with type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes. [Phase 3]
A Phase 3 pediatric trial comparing Glucovance (glyburide/metformin) with metformin and with glyburide in children and adolescents with Type…
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes [Phase 4]
Phase 4 study evaluating the mechanism by which Glucovance (metformin and glyburide) controls blood glucose in patients with Type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty [Phase 4]
A Phase 4 trial update on post-PCI cardiac imaging in patients with Type 2 diabetes mellitus has completed. The study aims to detect coronar…
-
FDA approval · 2011-04-14FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Januvia (sitagliptin) submitted by Merck Sharp & Dohme LLC. The action updates the regulatory st…
-
FDA approval · 2011-04-14FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET (sitagliptin/metformin hydrochloride) filed by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED) [Phase 3]
A Phase 3 trial evaluating sitagliptin and MK0431A against a commonly used medication in type 2 diabetes has completed, with results posted.
-
FDA approval · 2011-04-13FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental NDA for metformin hydrochloride, resulting in updated labeling for this product.
-
CLINICAL_TRIALS research · 2011-04-13Clinical Trial Update: Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes [NA]
A clinical trial update describing research on how gene expression profiles relate to the efficacy of metformin in Type 2 diabetes.
-
CLINICAL_TRIALS research · 2011-04-13Clinical Trial Update: The Surgical Treatment of Type 2 Diabetes Mellitus in Non-Morbidly Obese Patients: A Community Hospital Study [NA]
Clinical trial update examining surgical treatment for type 2 diabetes mellitus in non-morbidly obese adults at a community hospital; curren…
-
CLINICAL_TRIALS trial_result · 2011-04-11Clinical Trial Update: Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes [Phase 4]
Phase 4 trial comparing the efficacy and safety of Biphasic Insulin Aspart 30 with Biphasic Human Insulin 30 on blood sugar control in subje…
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone [Phase 3]
A Phase 3 trial evaluating saxagliptin added to metformin in type 2 diabetes patients not adequately controlled on metformin alone; the stud…
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: Avandamet Bioequivalence Study Brazil - Fed Administration [Phase 1]
Phase 1 bioequivalence study of Avandamet in Brazil completed; results posted.
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial investigates whether vitamin D supplementation affects inflammatory markers of cardiovascular disease in African Am…